BTK inhibitor 4b   Click here for help

GtoPdb Ligand ID: 10094

Synonyms: compound 4b [PMID: 30216722]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: This compound is reported as a selective inhbitor of Bruton's tyrosine kinase (BTK) [2]. Compared to existing BTK inhibitors it has a novel aminotriazine scaffold. Inhibitor 4b has been advanced to preclinical studies for evaluation of its anti-inflammatory potential. This is one of the chemical structures claimed in Carna Bioscience's patent WO2015012149A1 [3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 136.25
Molecular weight 498.19
XLogP 4.19
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES OCc1c(cccc1n1ccc2c(c1=O)c(F)cc(c2)C1CC1)c1nc(N)nc(n1)Nc1cnn(c1)C
Isomeric SMILES OCc1c(cccc1n1ccc2c(c1=O)c(F)cc(c2)C1CC1)c1nc(N)nc(n1)Nc1cnn(c1)C
InChI InChI=1S/C26H23FN8O2/c1-34-12-17(11-29-34)30-26-32-23(31-25(28)33-26)18-3-2-4-21(19(18)13-36)35-8-7-15-9-16(14-5-6-14)10-20(27)22(15)24(35)37/h2-4,7-12,14,36H,5-6,13H2,1H3,(H3,28,30,31,32,33)
1. Ellmeier W, Abramova A, Schebesta A. (2011)
Tec family kinases: regulation of FcεRI-mediated mast-cell activation.
FEBS J, 278 (12): 1990-2000. [PMID:21362140]
2. Kawahata W, Asami T, Kiyoi T, Irie T, Taniguchi H, Asamitsu Y, Inoue T, Miyake T, Sawa M. (2018)
Design and Synthesis of Novel Amino-triazine Analogues as Selective Bruton's Tyrosine Kinase Inhibitors for Treatment of Rheumatoid Arthritis.
J Med Chem, 61 (19): 8917-8933. [PMID:30216722]
3. Kawahata W, Asami T, Sawa M, Asamitsu Y, Irie T, Miyake T, Kiyoi T. (2015)
Novel triazine derivative.
Patent number: WO2015012149A1. Assignee: Carna Bioscience Inc. Priority date: 26/07/2013. Publication date: 29/01/2015.